4DMedical Limited (ASX:4DX)

4DMedical Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	5.85	3.75	0.72	1.05	0.22
Revenue Growth (YoY)	55.91%	422.45%	-31.84%	385.90%	-82.39%
Cost of Revenue	0.46	0.24	0.03	0.77	0.09
Gross Profit	5.39	3.52	0.68	0.28	0.13
Selling, General & Admin	32.1	27.83	23.74	19.21	11.43
Other Operating Expenses	15.46	16.65	18.95	16.32	12.26
Operating Expenses	52.89	48.55	45.25	37.03	24.46
Operating Income	-47.5	-45.03	-44.57	-36.75	-24.34
Interest Expense	-0.26	-0.26	-0.29	-0.18	-2.69
Interest & Investment Income	0.34	1.24	0.61	0.09	0.03
Currency Exchange Gain (Loss)	-0.6	0.35	-0.03	-0.03	0.04
Other Non Operating Income (Expenses)	18.51	10.97	13.15	12.32	5.55
EBT Excluding Unusual Items	-29.51	-32.74	-31.14	-24.55	-21.41
Merger & Restructuring Charges	-0.66	-3.19	-	-	-
Gain (Loss) on Sale of Assets	0.01	-	-	-	-
Pretax Income	-30.16	-35.93	-31.14	-24.55	-21.41
Income Tax Expense	-0.09	0.05	0.32	0.04	0.02
Net Income	-30.07	-35.98	-31.46	-24.59	-21.42
Net Income to Common	-30.07	-35.98	-31.46	-24.59	-21.42
Shares Outstanding (Basic)	424	370	300	295	261
Shares Outstanding (Diluted)	424	370	300	318	283
Shares Change (YoY)	14.52%	23.49%	-5.59%	12.14%	92.94%
EPS (Basic)	-0.07	-0.10	-0.10	-0.08	-0.08
EPS (Diluted)	-0.14	-0.11	-0.10	-0.08	-0.08
Free Cash Flow	-34.56	-31.02	-23.07	-27.92	-15.1
Free Cash Flow Per Share	-0.08	-0.08	-0.08	-0.09	-0.05
Gross Margin	92.07%	93.69%	95.25%	26.62%	57.67%
Operating Margin	-811.49%	-1199.53%	-6202.49%	-3485.78%	-11217.15%
Profit Margin	-513.72%	-958.34%	-4378.05%	-2332.63%	-9872.21%
Free Cash Flow Margin	-590.45%	-826.34%	-3211.05%	-2647.86%	-6957.55%
EBITDA	-46.05	-43.88	-43.83	-36.34	-24.15
D&A For EBITDA	1.45	1.16	0.74	0.41	0.18
EBIT	-47.5	-45.03	-44.57	-36.75	-24.34

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.